Abstract
Background and objectives
Wound blush represents angiographic visualisation of tissue-level perfusion around a diabetic foot ulcer. While wound blush after endovascular revascularisation (EVR) predicts improved outcomes, its’ prognostic value on diagnostic digital subtraction angiography (DSA) has not been studied, particularly in India. This study compared the role of wound blush after DSA and after EVR in predicting wound healing and limb salvage in non-healing diabetic foot ulcers.
Methods
A total of 428 individuals with diabetic foot ulcers underwent diagnostic DSA. Wound blush was assessed on DSA and, where applicable, after EVR. Participants were followed for wound healing and amputation outcomes. The wound blush positive and wound blush negative groups on DSA, among participants managed without EVR, and according to wound blush status following EVR were compared.
Results
On diagnostic DSA, 137(31.6%) participants were wound blush positive and 291(68.4%) were wound blush negative. Wound blush positive participants demonstrated higher rates of complete wound healing (90.5% vs. 79%; P=0.002), and lower amputation rates (7.6 vs. 22.2%; P<0.001) compared to wound blush negative participants. Among participants managed without EVR, limb salvage was significantly higher in wound blush positive than wound blush negative participants (92.4% vs.77.8%; P=0.002). Following EVR, limb salvage was achieved in 89% of participants who demonstrated wound blush compared to 77% (P=0.062) of those who remained wound blush negative. Baseline wound blush positivity predicted favourable outcomes irrespective of EVR.
Interpretation and conclusions
Wound blush on diagnostic angiography and after EVR is a strong predictor of wound healing and limb salvage in non-healing diabetic foot ulcers. Wound blush on initial DSA helps identifying participants in whom revascularisation may be deferred, reducing endovascular interventions without adverse limb outcomes.
Keywords: Angiography, Limb salvage, Non-healing diabetic foot ulcer, Wound blush
India has 90 million people with diabetes.1 Complications like neuropathy and vascular insufficiency lead to ulcers which result in hugely increased costs2 and lowered quality of life.3 Diabetic foot complications are increasing in both urban and rural India, with foot ulcers accounting for 85% of amputations.4 Neuropathic lesions contribute to 80% of these cases, while neuro-ischaemic lesions account for the remaining 20%.5 An estimated 100,000 limb amputations occur annually in India due to diabetes, with the incidence continually rising.6 Diabetic foot ulcers consume up to 20% of all healthcare expenditures for individuals with diabetes, surpassing any other diabetes-related complication.4 The mortality rates associated with diabetic foot ulcers and amputations are high, reaching 11% and 22%, respectively.2,5
Peripheral artery disease is a crucial risk factor for the development of foot ulcers, with up to 50% of people with diabetic foot ulcers exhibiting concomitant peripheral arterial disease.6-8 Critical limb-threatening ischaemia affects up to 10% of people with peripheral arterial disease and is associated with significant pain, amputation rate, impaired quality of life and mortality.9 While bypass surgery can achieve durable patency, it may be contraindicated in certain individuals due to factors such as inadequate surgical targets, lack of suitable conduits, advanced age, and co morbidities10 Therefore we need to look for indicators that will help us to decide on treatment modalities other than the bypass.
Wound blush is the visibility of red colour in the tissue around the wound which is an indication of adequate blood flow. This may help to quantify if revascularisation is necessary. However, this has not been adequately investigated. Revascularisation via endovascular revascularisation (EVR) or bypass surgery is crucial for limb salvage and to improve quality of life and prolong survival in people with chronic limb threatening ischaemia.11 Wound blush after angioplasty as a predictor of successful outcomes has been proposed by Utsunomiya from Japan where he showed that wound blush after angioplasty has the potential to predict favourable outcomes.12 It has also been studied by another group from Egypt.13 There are no studies on wound blush and its’ potential prognostic significance from India.
As a minimally invasive alternative to bypass surgery, endovascular revascularisation offers an effective revascularisation option and has demonstrated comparable limb salvage and mortality rates to bypass surgery.12 Even in the presence of a patent bypass, approximately 15% of people with ischaemic lower extremity ulcers eventually require major amputation.14-17 This study aims to assess the role of wound blush, a potential angiographic indicator, among individuals with diabetic foot ulcers and its impact on limb salvage outcomes.
Methods
Study design and participants
This paper reports on individuals treated for diabetic foot ulcers at M V Hospital for Diabetes in Chennai, South India, between October 2020 and December 2024. This study has been cleared by the Institutional Ethics Committee of the Prof. M. Viswanathan Diabetes Research Centre. Participants with non-healing diabetic foot ulcers who underwent digital subtraction angiography (DSA)(n=428) during the study period were included in the study. Exclusion criteria comprised inability to maintain the necessary positioning during the DSA procedure. Of these, 206 were willing to undergo revascularisation procedures. Demographic data, clinical characteristics, personal habits, co morbidities, and the presence of other complications were recorded for each participant on a standardised case reporting form. The wound ulcers were graded using the University of Texas Wound Classification (TWC) for diabetic foot ulcers.18,19
Study procedure
Wound blush was evaluated and recorded after the DSA by observation by a single trained standardised interventional radiologist. Wound blush positivity was defined as contrast opacification of the vessels surrounding the wound, while wound blush negativity was defined as the absence of contrast opacification around the wound area. Wound blush was considered the terminal endpoint of the EVR procedure. However, the presence or absence of wound blush did dot guide the decision to undertake revascularisation procedures.
All EVR procedures were performed under local anaesthesia. A 6-French sheath was typically introduced via an ante grade approach from the ipsilateral or contralateral common femoral artery. Unfractionated heparin (5,000 units) was routinely administered intra-arterially after sheath insertion. A 0.35/0.18/0.14-inch guide wire was advanced to the culprit lesion, followed by balloon angioplasty using an optimally sized balloon catheter. Stent implantation in the iliac, superficial femoral, or popliteal arteries was performed at the operator’s discretion when necessary. The balloon size was determined based on the diameter of the distal healthy vessel segment. After successful revascularisation, a complete angiographic run was obtained with contrast injection in the arteries. Wound blush was also assessed again after endovascular revascularisation
Follow up and evaluation
Postoperatively, surgical debridement was performed as necessary in cases of wound infection. Participants were followed up for a minimum of 6 months after the EVR procedure. The status of the ulcer and the amputation were recorded during this period. Complete wound healing was defined as the achievement of complete epithelialisation of all wounds without death or major amputation. Minor amputation referred to amputation below the calcaneus bone (ankle level), while major amputation referred to transfemoral or transtibial knee amputation. All participants were followed for their healing status. Limb salvage was defined as the absence of major amputation during the observation period, indicating preservation of a functional lower extremity. Limb salvage included healing, healing with skin graft and minor infra-calcaneal amputation.
Statistical analysis
Relevant data were extracted from the institutional database and entered into Microsoft Excel. Statistical analysis was performed using SPSS software version 21.0 (IBM Corp., Armonk, NY, USA). Continuous variables are presented as mean ± standard deviation (SD) and categorical variables as frequencies and percentages. P value <0.05 was considered statistically significant. The analytical framework was predefined to evaluate the prognostic role of wound blush on angiography and its relationship with limb salvage and wound healing outcomes.
The primary or foundational analysis compared participants demonstrating wound blush positive versus wound blush negative on diagnostic digital subtraction angiography (DSA), prior to any endovascular intervention. This comparison reflects baseline physiological microvascular perfusion and is independent of treatment-related effects. Outcomes assessed included limb salvage rate, complete wound healing rate, and major amputation rate.
A secondary analysis was performed among participants who did not undergo endovascular revascularisation (EVR) (n=222) to identify the EVR independent prognostic value. Outcomes in wound blush positive and wound blush negative group managed without EVR were compared to determine whether baseline wound bush alone could predict limb salvage and wound healing.
For the tertiary analysis of EVR as a modifier rather than the principal determinant of outcome, participants were categorised based on wound blush status across the treatment course: (a) wound blush positive on diagnostic DSA; (b) wound blush negative on diagnostic DSA converting to wound blush positive following EVR; and (c) persistently wound blush negative despite EVR. This analysis assessed whether achievement of wound blush at any stage of management was associated with improved limb salvage and wound healing outcomes.
Categorical variables, including limb salvage, wound healing, and amputation rates, were compared using the Chi-square test or Fisher’s exact test, as appropriate. Where relevant, subgroup analyses were performed to support interpretation of findings.
Results
A total of 428 participants with non-healing diabetic foot ulcers underwent DSA. Of the 428 participants who underwent DSA, 137 (31.6%) were positive for wound blush and 291 (68.4%) were negative. Among these, 32 participants from the wound blush positive group and 174 participants from the wound blush negative group consented to undergo revascularisation ( Fig. 1). Participants deemed unsuitable for revascularisation or those unwilling for revascularisation were referred for debridement or other surgical intervention according to the interventional radiologist’s recommendation. 105 of the 137 wound blush positive group and 117 of the 291 wound blush negative group (n=222) did not undergo EVR.
Fig. 1.

Flow chart of the course in the hospital of participants with diabetic foot ulcer who underwent digital subtraction angiography (DSA) followed by endovascular revascularisation (EVR).
Baseline demographic, clinical, wound-related, and angiographic characteristics of the study population stratified by wound blush status on diagnostic DSA are presented in Table I. The two groups were largely comparable with respect to age, glycaemic control, comorbidities, wound depth, and infection status. The distribution of participants according to the Texas wound classification grade is given in Table II.
Table I.
Baseline characteristics of the persons who underwent digital subtraction angiography (N=428)
| Characteristic | Wound blush positive, n=137 | Wound blush negative, n=291 | P value |
|---|---|---|---|
| Age in y | |||
|
Mean (SD) Range |
63 (9.7) 35 to 85 |
64 (9.3) 33 to 98 |
0.31 |
| Gender; n (%) | |||
|
Male Female |
112 (81.8) 25 (18.2) |
230 (79) 61 (21) |
0.51 |
| Affected limb; n (%) | |||
|
Left leg Right leg |
55 (40) 82 (60) |
173 (59.5) 118 (40.5%) |
<0.001 |
| Affected vessels; n (%) | |||
|
Infra popliteal Infra inguinal Site not mentioned |
112 (81.8%) 20 (14.6%) 5 (3.6%) |
221 (75.9%) 70 (24.1%) 0 |
<0.001 |
| HbA1c %; n (%) | |||
|
<6 6.1 to 8 8.1 to 10 >10 |
3 (2.2) 32 (23.3) 49 (35.8) 53 (38.7) |
12 (4.1) 80 (27.5) 93 (32) 106 (36.4) |
0.54 |
| Peripheral artery disease; n (%) | 115 (84) | 257 (88) | 0.21 |
| Wound characteristics | |||
| Location of ulcer; n (%) | |||
|
Forefoot Midfoot Hind foot Above knee Below knee |
90 (64.9) 16 (11.6) 27 (19.7) 0 -- 4 (2.9) |
218 (73) 20 (7) 31 (10.6) 2 (0.6) 20 (7) |
0.012 |
| Type of wound; n (%) | |||
|
Infected Ischemic Gangrenous |
15 (10.9) 113 (82.4) 9 (6) |
21 (7.2) 259 (89) 11 (3.7) |
0.169 |
| Depth of wound | |||
|
Superficial Involving tendons/capsule Involving bone |
14 (10) 53 (38.6) 69 (50.3) |
22 (7.5) 63 (21.6) 204 (70) |
<0.001 |
Table II.
Wound Grades based on Texas wound classification for diabetic foot ulcers
|
Texas Wound Grade classification Category |
After Angiogram |
||
|---|---|---|---|
|
Wound blush Positive (n=137); n (%) |
Wound blush Negative (n=291); n (%) |
Total (n=428); n (%) |
|
| I B | 1 (0.7) | 2 (0.7) | 3 (0.7) |
| I C | 7 (5.1) | 8 (2.8) | 15 (3.5) |
| I D | 7 (5.1) | 15 (5.1) | 22 (5.1) |
| II B | 5 (3.7) | 0 (0) | 5 (1.2) |
| II C | 23 (16.8) | 23 (7.9) | 46 (10.8) |
| II D | 25 (18.2) | 35 (12) | 60 (14) |
| III B | 2 (1.5) | 2 (0.7) | 4 (1) |
| III C | 3 (2.2) | 16 (5.5) | 19 (4.4) |
| III D | 64 (46.7) | 190 (65.3) | 254 (59.3) |
The flow of participants through diagnostic angiography, revascularisation, wound blush status, and clinical outcomes is illustrated in Figure 1. All the 428 individuals had a digital subtraction angiography at intake. Of these 137 were wound blush positive and 291 were wound blush negative. 105 wound blush positive and 117 of the wound blush negative group did not have an endovascular revascularisation; and 8 (7.6%) of the former and 26 (22.3%) of the latter needed amputation (P<0.001). The detailed analysis of these groups is given in Tables III and IV.
Table III.
Healing status in relation to wound blush after diagnostic subtraction angiography and endovascular revascularisation among the study participants
| Wound blush status after angiogram (DSA) | Wound blush status after subsequent angioplasty (EVR) | Total (n=428) | Healing status |
|||||
|---|---|---|---|---|---|---|---|---|
| Healed (n=107) A | Healing (n=176) B |
SSG/SSR (n=44) C |
Healed/Healing in progress (n=327) (A+B+C); n (%) |
Not healed (n=74); n (%) |
INA (n=27) |
|||
| Positive | Positive | 27 | 9 | 17 | 0 | 26 (96.3) | 1 (3.7) | 0 (0) |
| Negative | 3 | 2 | 0 | 0 | 2 (66.7) | 1 (33.3) | 0 (0) | |
| EVR not done | 105 | 28 | 46 | 13 | 87 (82.9) | 11 (10.5) | 7 (6.7%) | |
| EVR done but WB status not available | 2 | 0 | 1 | 1 | 2 (100) | 0 (0) | 0 (0) | |
| Negative | Positive | 146 | 39 | 66 | 18 | 123 (84.2) | 14 (9.6) | 9 (6.2%) |
| Negative | 27 | 8 | 11 | 2 | 21 (77.8) | 5 (18.5) | 1 (3.7%) | |
| EVR not done | 117 | 20 | 35 | 10 | 65 (55.6) | 42 (35.9) | 10 (8.5%) | |
| EVR done but WB status not available | 1 | 1 | 0 | 0 | 1 (100) | 0 (0) | 0 (0) | |
SSR, split skin grafting/secondary suturing, INA, information not available
Table IV.
Proportion of limb salvage and amputation after diagnostic subtraction angiography and endovascular revascularisation among the study participants
| Wound blush status after angiogram (DSA) | Wound blush status after subsequent angioplasty (EVR) | Total number (n=428) | Amputation status |
|
|---|---|---|---|---|
| Amputation (n=59); n (%) | Limb salvage (n=369); n (%) | |||
| Positive | Positive | 27 | 1 (3.7) | 26 (96.3) |
| Negative | 3 | 3 (100) | ||
| EVR not done | 105 | 8 (7.6) | 97 (92.4) | |
| EVR done but wound blush status not available | 2 | 2 (100) | ||
| Negative | Positive | 145 | 18 (12.4) | 127 (87.6) |
| Negative | 28 | 6 (21.4) | 22 (78.6) | |
| EVR not done | 117 | 26 (22.2) | 91 (77.8) | |
| EVR done but wound blush status not available | 1 | 1 (100) | ||
DSA, digital subtraction angiography; EVR, endovascular revascularization
The prognostic significance of wound blush on diagnostic DSA prior to any intervention was first evaluated. Participants in the wound blush positive (85.4%) group demonstrated significantly better wound-healing compared to those in the wound blush negative (72.2%) group. Comparing the two panels in Table III, it is seen that wound healing was achieved in a higher proportion of wound blush positive than wound blush negative participants (96.3% vs. 84.2%; P<0.001) even though they become positive after EVR ( Table III). Non-healing wounds were less common in the wound blush positive compared to the wound blush negative group (9.6% vs. 21%) based on wound blush seen in DSA. Major amputation was less among wound blush positive compared to wound blush negative participants (6.6% vs. 17.2%) whereas limb salvage was more among them compared to wound blush negative participants (93.4% vs. 82.8%; P=0.003) ( Table IV).
Among the 222 participants who did not undergo EVR, wound blush status on diagnostic angiography remained a significant determinant of outcomes. Limb salvage was achieved in 92.4% of participants who were wound blush positive on diagnostic DSA, compared to 77.8% of those who were wound blush negative ( Table IV). Amputation rates were significantly higher in wound blush negative participants who did not undergo EVR. Healing outcomes also favoured the wound blush positive group in the absence of revascularisation. A higher proportion of wound blush positive participants achieved complete or ongoing healing, while non-healing wounds was more frequent among wound blush negative participants ( Table III).
A total of 206 participants underwent EVR ( Fig. 1). Among participants who achieved wound blush positivity after EVR, limb salvage was achieved in 154 of 173 cases (89%), compared to 23 of 30 cases (77%) among those who remained wound blush negative following EVR (P=0.062). Further stratified analysis revealed that participants who were wound blush positive on initial diagnostic angiography exhibited high limb salvage rates irrespective of post-EVR wound blush status. In contrast, among participants who were wound blush negative on diagnostic angiography, limb salvage was significantly higher in those who converted to wound blush positive after EVR compared to those who remained wound blush negative (87.6% vs. 78.6%). Participants who remained persistently wound blush negative despite EVR demonstrated the poorest healing outcomes ( Table III) and highest amputation rates ( Table IV).
In a total of 173 wound blush positive cases, limb salvage was achieved in 154, out of whom 73 (47.4%) had cardiac conditions and of the 19 who lost their limb 10 (52.6%) had cardiac conditions. In a total of 32 wound blush negative cases, limb salvage was achieved in 23, out of whom 13 (56.5%) had cardiac condition and of the 6 who lost their limb 4 had cardiac condition. There were no deaths during 6 mo follow up period (data not shown).
Representative angiographic images before and after EVR demonstrating the development of wound blush are shown in Figure 2.
Fig. 2.

Digital subtraction angiography for an occluded posterior tibial artery. (A) Represents status before EVR where there is no evidence of wound blush. (B) Represents the status after EVR where the wound blush is noted.
Discussion
The present study demonstrates that delivery of blood to the wound bed is central to wound healing in diabetic ulcers and that angiographic wound blush is a reliable surrogate marker of effective microvascular perfusion. A key and novel observation of this study is that wound blush on diagnostic angiography prior to any intervention serves as a strong baseline prognostic marker. Participants who were wound blush positive on presentation demonstrated higher healing rates and superior limb salvage outcomes compared to wound blush negative participants. These findings support wound blush as a clinically meaningful angiographic endpoint rather than angiographic patency alone.
These favourable outcomes were observed even among individuals with multilevel arterial disease, underscoring that effective microvascular perfusion at the wound level may persist despite proximal occlusions. This finding highlights the physiological relevance of wound blush as a marker of tissue-level perfusion and extends its prognostic value beyond the post-revascularisation setting.
The most clinically impactful finding of this study is the demonstration that baseline wound blush predicts outcomes even in the absence of EVR. Among participants managed without revascularisation, those who were wound blush positive on diagnostic angiography had substantially higher limb salvage rates and better healing outcomes compared to wound blush negative participants. This suggests that diagnostic wound blush may help identify a subset of people in whom conservative or deferred revascularisation strategies could be safely considered, thereby avoiding unnecessary interventions and their associated risks.
In participants who underwent EVR, achievement of wound bush following the procedure was associated with improved limb salvage and wound healing outcomes. However, EVR primarily acted as an outcome modifier, facilitating the development of wound blush in participants who were wound blush negative at baseline. Participants who converted from wound blush negative to wound blush positive following EVR demonstrated significantly better outcomes than those who remained persistently negative for wound blush. Conversely, participants who were wound blush positive on diagnostic angiography exhibited favourable outcomes regardless of post- revascularisation wound blush status, further emphasising that baseline microvascular perfusion is a dominant determinant of prognosis. ‘Angioplasty First’ approach policy also states that the adequate supply of blood needs to be ensured for the wound healing and quicker recovery.20 Even after adjusting for the severity of chronic limb threatening ischaemia in the affected limb or overall health, wound blush remained as an independent predictor. These findings are consistent with earlier work by Utsunomiya et al,12 who demonstrated that post-EVR wound blush was an independent predictor of ulcer healing. These findings in his study imply that it is crucial for blood to be delivered to the wound for healing the ulcer. Our study has shown the same findings.
The clinical findings were not influenced by renal insufficiency, or advanced age separately.21 The presence of wound blush is a reliable indicator of the speed and duration of wound healing.22 In our study we found the same thing; but in addition, that the post revascularisation wound blush positivity was related to the major amputation free survival and wound healing. Thus, angioplasty can be considered for limb salvage before attempting other procedures like bypass or amputation.
Unlike conventional angiographic endpoints that focus on vessel patency or angiosome-directed flow, wound blush provides a direct visual assessment of perfusion at the wound site. This may explain why wound blush outperformed anatomical descriptors of arterial disease severity in predicting clinical outcomes. The results of this study support a shift in emphasis from purely anatomical revascularisation goals to physiological endpoints that reflect tissue-level perfusion.
The strengths of this study include a large and well-characterised cohort, standardised wound classification, clearly defined clinical outcomes, and comprehensive follow up. Several limitations merit consideration. The single-centre design may limit generalisability. Assessment of wound blush was based on visual interpretation, introducing potential observer subjectivity. Follow up duration was limited to early healing outcomes, and detailed quantitative perfusion measurements were not available.
This study demonstrates that wound blush on diagnostic angiography and after EVR is a strong predictor of wound healing and limb salvage in participants with non-healing diabetic foot ulcers. Wound blush on presentation identifies patients with favourable prognosis, even without revascularisation, while absence of wound blush highlights a high-risk subgroup that may benefit from aggressive intervention aimed at achieving tissue-level perfusion. Incorporation of wound blush assessment into routine angiographic evaluation may improve risk stratification, guide treatment decisions, and ultimately enhance limb preservation outcomes.
शोध-संदेश
मधुमेह के रोगियों में लम्बी जटिताओं में पैर में होने वाले घाव प्रमुख है, जो नसों की कमजोरी और पेरो में रक्त के काम संचार से होते है। लम्बे समय तक घाव न भरने की स्थिति में पैर या उसकी उंगलियों को काटने की नौबत आ सकती है। इन घावों के इलाज और एंजियोग्राफी के दौरान वाउंड ब्लश (wound blush, घाव के पास दिखने वाली एक लाली या चमक) का होना एक सकरात्मक संकेत है जिससे पता चलता है की घाव वाले हिस्से में रक्त संचार हो रहा है। इस अध्ययन में पाया गया कि न भरने वाले मधुमेहजनित पैर के घावों (diabetic foot ulcers) में वाउंड ब्लश (Wound Blush) घाव भरने और अंग बचाने का एक विश्वसनीय संकेतक है। प्रारंभिक एंजियोग्राफी (DSA) में इसकी उपस्थिति से ऐसे मरीजों की पहचान की जा सकती है, जिनमें एंडोवैस्कुलर रीवैस्कुलराइजेशन (endovascular revascularisation, EVR) यानी रक्त प्रवाह को पुनः स्थापित करने की प्रक्रिया को टाला जा सकता है, जिससे अनावश्यक हस्तक्षेप कम किए जा सकते हैं।
Acknowledgment
Authors acknowledge Ms. Nazeemunnisa for extraction of data from main data base; other staff for data collection and Dr. Swathikiran Rajkumar for revising and restructuring the manuscript.
Footnotes
How to cite this article: Vijay V, Sivala DB, Radhakrishnan R, Devarajan A, Ahmed Khan B, Nachimuthu S, et al. Wound blush as a predictor for limb salvage among people with non-healing diabetic foot ulcers. Indian J Med Res. 2026;164:765-72. doi: 10.25259/IJMR_3343_2025
Author contributions
VV: Concept, design, manuscript review; RR: Data acquisition, manuscript writing; SNM: Data acquisition; DBS: Data acquisition, data analysis, manuscript writing; BAK: Data acquisition, data analysis; AD: Data analysis, manuscript writing; SK: Manuscript review; MD: Data analysis, manuscript writing. All authors have read and approved the final printed version of the manuscript.
Financial support and sponsorship
None.
Conflicts of Interest
None.
Use of Artificial Intelligence (AI)-Assisted Technology for manuscript preparation
The authors confirm that there was no use of AI-assisted technology for assisting in the writing of the manuscript and no images were manipulated using AI.
References
- 1.Duncan BB, Magliano DJ, Boyko EJ. IDF Diabetes Atlas 11th edition 2025: Global prevalence and projections for 2050. Nephrol Dial Transplant. 2025;41:7–9. doi: 10.1093/ndt/gfaf177. [DOI] [PubMed] [Google Scholar]
- 2.Cavanagh P, Attinger C, Abbas Z, Bal A, Rojas N, Xu ZR. Cost of treating diabetic foot ulcers in five different countries. Diabetes Metab Res Rev. 2012;28s:107–11. doi: 10.1002/dmrr.2245. [DOI] [PubMed] [Google Scholar]
- 3.Viswanathan V. The diabetic foot: Perspectives from Chennai, South India. Int J Low Extrem Wounds. 2007;6:34–6. doi: 10.1177/1534734606297987. [DOI] [PubMed] [Google Scholar]
- 4.Sinharay K, Paul UK, Bhattacharyya AK, Pal SK. Prevalence of diabetic foot ulcers in newly diagnosed diabetes mellitus patients. J Indian Med Assoc. 2012;110:608–11. [PubMed] [Google Scholar]
- 5.Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: A systematic review and meta-analysis. Ann Med. 2017;49:106–1. doi: 10.1080/07853890.2016.1231932. [DOI] [PubMed] [Google Scholar]
- 6.Jeffcoate WJ, Chipchase SY, Ince P, Game FL. Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures. Diabetes Care. 2006;29:1784–7. doi: 10.2337/dc06-0306. [DOI] [PubMed] [Google Scholar]
- 7.Beckert S, Witte M, Wicke C, Königsrainer A, Coerper S. A new wound-based severity score for diabetic foot ulcers: A prospective analysis of 1,000 patients. Diabetes Care. 2006;29:988–92. doi: 10.2337/diacare.295988. [DOI] [PubMed] [Google Scholar]
- 8.Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II) J Vasc Surg. 2007;45:S5–67. doi: 10.1016/j.jvs.2006.12.037. [DOI] [PubMed] [Google Scholar]
- 9.Allie DE, Hebert CJ, Lirtzman MD, Wyatt CH, Keller VA, Khan MH, et al. Critical limb ischemia: A global epidemic. A critical analysis of current treatment unmasks the clinical and economic costs of CLI. EuroIntervention. 2005;1:75–84. [PubMed] [Google Scholar]
- 10.Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): Multicentre, randomised controlled trial. Lancet. 2005;366:1925–34. doi: 10.1016/S0140-6736(05)67704-5. [DOI] [PubMed] [Google Scholar]
- 11.Kudo T, Chandra FA, Kwun WH, Haas BT, Ahn SS. Changing pattern of surgical revascularization for critical limb ischemia over 12 years: Endovascular vs. open bypass surgery. J Vasc Surg. 2006;44:304–13. doi: 10.1016/j.jvs.2006.03.040. [DOI] [PubMed] [Google Scholar]
- 12.Utsunomiya M, Takahara M, Iida O, Yamauchi Y, Kawasaki D, Yokoi Y, et al. Wound blush obtainment is the most important angiographic endpoint for wound healing. JACC Cardiovasc Interv. 2017;10:188–94. doi: 10.1016/j.jcin.2016.10.026. [DOI] [PubMed] [Google Scholar]
- 13.Shahat M, Taha AG, Elnaggar A, Aboloyoun H. Can wound blush be used as an indicator for termination of endovascular procedures in chronic limb-threatening ischemia patients? Vascular. 2025. 33:1128–34. doi: 10.1177/17085381241283096. [DOI] [PubMed] [Google Scholar]
- 14.Elliott BM, Robison JG, Brothers TE, Cross MA. Limitations of peroneal artery bypass grafting for limb salvage. J Vasc Surg. 1993;18:881–8. doi: 10.1067/mva.1993.49636. [DOI] [PubMed] [Google Scholar]
- 15.Johnson BL, Glickman MH, Bandyk DF, Esses GE. Failure of foot salvage in patients with end-stage renal disease after surgical revascularization. J Vasc Surg. 1995;22:280–5. doi: 10.1016/s0741-5214(95)70142-7. [DOI] [PubMed] [Google Scholar]
- 16.Berceli SA, Chan AK, Pomposelli FB, Gibbons GW, Campbell DR, Akbari CM, et al. Efficacy of dorsal pedal artery bypass in limb salvage for ischemic heel ulcers. J Vasc Surg. 1999;30:499–508. doi: 10.1016/s0741-5214(99)70077-7. [DOI] [PubMed] [Google Scholar]
- 17.Treiman GS, Oderich GS, Ashrafi A, Schneider PA. Management of ischemic heel ulceration and gangrene: An evaluation of factors associated with successful healing. J Vasc Surg. 2000;31:1110–8. doi: 10.1067/mva.2000.106493. [DOI] [PubMed] [Google Scholar]
- 18. International Working Group on the Diabetic Foot. IWGDF Guidelines on the Prevention and Management of Diabetic Foot Disease. Brussels: 2019. Available from: https://iwgdfguidelines.org/wp-content/uploads/2019/05/07-IWGDF-classification-guideline-2019.pdf, accessed on October 24, 2025.
- 19.Oyibo SO, Jude EB, Tarawneh I, Nguyen HC, Harkless LB, Boulton AJ. A comparison of two diabetic foot ulcer classification systems: The Wagner and the University of Texas wound classification systems. Diabetes Care. 2001;24:84–8. doi: 10.2337/diacare.24.1.84. [DOI] [PubMed] [Google Scholar]
- 20.Ni WW, Leong S, Irani F, Patel A, Damodharan K, Venkataranasimha N, et al. “Angioplasty-first” approach for limb salvage in Asian patients with critical limb ischemia: outcomes from 3,303 angioplasties on 2,402 limbs in a single tertiary hospital. J Vasc Interv Radiol. 2020;31:1969–77. doi: 10.1016/j.jvir.2020.08.008. [DOI] [PubMed] [Google Scholar]
- 21.Tefera G, Hoch J, Turnipseed WD. Limb-salvage angioplasty in vascular surgery practice. J Vasc Surg. 2005;41:988–93. doi: 10.1016/j.jvs.2005.03.018. [DOI] [PubMed] [Google Scholar]
- 22.Reed GW, Salehi N, Giglou PR, Kafa R, Malik U, Maier M, et al. Time to wound healing and major adverse limb events in patients with critical limb ischemia treated with endovascular revascularization. Ann Vasc Surg. 2016;36:190–8. doi: 10.1016/j.avsg.2016.02.032. [DOI] [PubMed] [Google Scholar]
